About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [4,840 citations: 1,201–1,300 of 3,873 articles]

Articles published in PPAR Research have been cited 4,840 times. The following is a list of the 3,873 articles that have cited the articles published in PPAR Research.

  • Anna Oksaharju, Riina A. Kekkonen, Riitta Korpela, Teake Kooistra, Wim van Duyvenvoorde, Jani Lappalainen, Ken A. Lindstedt, Petri T. Kovanen, Robert Kleemann, and Minja Miettinen, “Effects of probiotic Lactobacillus rhamnosus GG and Propionibacterium freudenreichii ssp shermanii JS supplementation on intestinal and systemic markers of inflammation in ApoE*3Leiden mice consuming a high-fat diet,” British Journal Of Nutrition, vol. 110, no. 1, pp. 77–85, 2013. View at Publisher · View at Google Scholar
  • Nurhan Sahin, Kazim Sahin, Osman Kucuk, Cemal Orhan, James R. Komorowski, Mehmet Tuzcu, Ibrahim H. Ozercan, and Vijaya Juturu, “Anti-diabetic activity of chromium picolinate and biotin in rats with type 2 diabetes induced by high-fat diet and streptozotocin,” British Journal Of Nutrition, vol. 110, no. 2, pp. 197–205, 2013. View at Publisher · View at Google Scholar
  • Vishal Singh, Manish Jain, Ankita Misra, Vivek Khanna, Minakshi Rana, Prem Prakash, Richa Malasoni, Anil Kumar Dwivedi, Madhu Dikshit, and Manoj Kumar Barthwal, “Curcuma oil ameliorates hyperlipidaemia and associated deleterious effects in golden Syrian hamsters,” British Journal of Nutrition, vol. 110, no. 3, pp. 437–446, 2013. View at Publisher · View at Google Scholar
  • Ashild Krogdahl, Anne Marie Bakke, Trond M. Kortner, and Jinni Gu, “Transcriptional regulation of cholesterol and bile acid metabolism after dietary soyabean meal treatment in Atlantic salmon (Salmo salar L.).,” British Journal Of Nutrition, vol. 109, no. 4, pp. 593–604, 2013. View at Publisher · View at Google Scholar
  • Fergus P McCarthy, Aoife C Delany, Louise C Kenny, and Sarah K Walsh, “PPAR-γ - a possible drug target for complicated pregnancies,” British Journal of Pharmacology, vol. 168, no. 5, pp. 1074–1085, 2013. View at Publisher · View at Google Scholar
  • Ac Simões e Silva, Kd Silveira, Aj Ferreira, and Mm Teixeira, “ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis,” British Journal of Pharmacology, vol. 169, no. 3, pp. 477–492, 2013. View at Publisher · View at Google Scholar
  • E. M. Stakhneva, V. A. Vavilin, Yu. I. Ragino, O. G. Safronova, A. B. Shintyapina, and M. V. Ivanova, “Effects of Simvaglyzin and Atorvaglyzin on the Expression of 3-Hydroxy-3-Methyl-Glutaryl-CoA Reductase in Rat Liver,” Bulletin of Experimental Biology and Medicine, 2013. View at Publisher · View at Google Scholar
  • V. A. Vavilin, D. L. Nepomnyashchikh, E. G. Shchepotina, Yu. Yu. Karavaeva, S. I. Makarova, E. V. Vinogradova, A. V. Kudryashov, Zh. V. Nokhrina, and V. V. Lyakhovich, “Cytochrome P450 4F2 Polymorphism in Patients with Liver Cirrhosis,” Bulletin of Experimental Biology and Medicine, 2013. View at Publisher · View at Google Scholar
  • Cameron McDonald, Judy Bauer, and Sandra Capra, “Omega-3 fatty acids and changes in LBM: alone or in synergy for better muscle health?,” Canadian Journal Of Physiology And Pharmacology, vol. 91, no. 6, pp. 459–468, 2013. View at Publisher · View at Google Scholar
  • Carani Venkatraman Anuradha, “ Phytochemicals targeting genes relevant for type 2 diabetes 1 ,” Canadian Journal of Physiology and Pharmacology, vol. 91, no. 6, pp. 397–411, 2013. View at Publisher · View at Google Scholar
  • Hala Fahmy Zaki, and Rania Mohsen Abdelsalam, “Vinpocetine protects liver against ischemia–reperfusion injury,” Canadian Journal of Physiology and Pharmacology, pp. 1–7, 2013. View at Publisher · View at Google Scholar
  • Tony Antoniou, Ximena Camacho, Zhan Yao, Tara Gomes, David N. Juurlink, and Muhammad M. Mamdani, “Comparative effectiveness of angiotensin-receptor blockers for preventing macrovascular disease in patients with diabetes: a population-based cohort study,” Canadian Medical Association Journal, vol. 185, no. 12, pp. 1035–1041, 2013. View at Publisher · View at Google Scholar
  • Jiaqi Dai, Hongxia Wang, Ying Dong, Yinxin Zhang, and Jian Wang, “Bile Acids Affect the Growth of Human Cholangiocarcinoma via NF-kB Pathway,” Cancer Investigation, vol. 31, no. 2, pp. 111–120, 2013. View at Publisher · View at Google Scholar
  • Iwona Podzielinski, Brook A. Saunders, Kimberly D. Kimbler, Adam J. Branscum, Eric T. Fung, Paul D. DePriest, John R. van Nagell, Frederick R. Ueland, and Andre T. Baron, “Apolipoprotein Concentrations Are Elevated in Malignant Ovarian Cyst Fluids Suggesting That Lipoprotein Metabolism Is Dysregulated in Epithelial Ovarian Cancer,” Cancer Investigation, vol. 31, no. 4, pp. 258–272, 2013. View at Publisher · View at Google Scholar
  • Satyanarayana R. Pondugula, and Sridhar Mani, “Pregnane xenobiotic receptor in cancer pathogenesis and therapeutic response,” Cancer Letters, vol. 328, no. 1, pp. 1–9, 2013. View at Publisher · View at Google Scholar
  • Yexiong Tan, Peiyuan Yin, Guozhu Ye, Qiang Huang, Peng Gao, Guowang Xu, Xin Lu, and Hongyang Wang, “Metabolic Characterization of Hepatocellular Carcinoma Using Nontargeted Tissue Metabolomics,” Cancer Research, vol. 73, no. 16, pp. 4992–5002, 2013. View at Publisher · View at Google Scholar
  • Junfeng Xiao, Bhaskar Kallakury, Yuhzi Yin, Levy Kopelovich, Jin Lu, Rachel Umans, Robert I. Glazer, Hongyan Yuan, Geeta Upadhyay, and Michael E. Fant, “PPAR delta Induces Estrogen Receptor-Positive Mammary Neoplasia through an Inflammatory and Metabolic Phenotype Linked to mTOR Activation,” Cancer Research, vol. 73, no. 14, pp. 4349–4361, 2013. View at Publisher · View at Google Scholar
  • Mary Kathryn Doud, Noa Noy, Liraz Levi, Darcie Seachrist, Glenn Lobo, Johannes von Lintig, and Gregory P. Tochtrop, “Genetic Ablation of the Fatty Acid-Binding Protein FABP5 Suppresses HER2-Induced Mammary Tumorigenesis,” Cancer Research, vol. 73, no. 15, pp. 4770–4780, 2013. View at Publisher · View at Google Scholar
  • Mark V. Boekschoten, Jan Dekker, Arjan Schonewille, Noortje Ijssennagger, Anneke Rijnierse, Michael Muller, Nicole J. W. de Wit, and Roelof van der Meer, “Dietary heme induces acute oxidative stress, but delayed cytotoxicity and compensatory hyperproliferation in mouse colon,” Carcinogenesis, vol. 34, no. 7, pp. 1628–1635, 2013. View at Publisher · View at Google Scholar
  • Alberto Izzotti, Roumen Balansky, Francesco D'Agostini, Mariagrazia Longobardi, Cristina Cartiglia, Sebastiano La Maestra, Rosanna T. Micale, Anna Camoirano, Gancho Ganchev, Marietta Iltcheva, Vernon E. Steele, and Silvio De Flora, “Relationships between pulmonary micro-RNA and proteome profiles, systemic cytogenetic damage and lung tumors in cigarette smoke-exposed mice treated with chemopreventive agents,” Carcinogenesis, vol. 34, no. 10, pp. 2322–2329, 2013. View at Publisher · View at Google Scholar
  • Jing Sun, Yunfei Pu, Peijian Wang, Sijiao Chen, Yu Zhao, Chan Liu, Qianhui Shang, Zhiming Zhu, and Daoyan Liu, “TRPV1-mediated UCP2 upregulation ameliorates hyperglycemia-induced endothelial dysfunction,” Cardiovascular Diabetology, vol. 12, no. 1, pp. 69, 2013. View at Publisher · View at Google Scholar
  • Dudu Sengwayo, Mpho Moraba, and Shirley Motaung, “Association of homocysteinaemia with hyperglycaemia, dyslipidaemia, hypertension and obesity,” Cardiovascular Journal of Africa, vol. 24, no. 7, pp. 265–269, 2013. View at Publisher · View at Google Scholar
  • Vivek Vaish, Honit Piplani, Chandan Rana, and Sankar Nath Sanyal, “Angiostatic Properties of Sulindac and Celecoxib in the Experimentally Induced Inflammatory Colorectal Cancer,” Cell Biochemistry And Biophysics, vol. 66, no. 2, pp. 205–227, 2013. View at Publisher · View at Google Scholar
  • J. Hanus, H. Zhang, Z. Wang, Q. Liu, Q. Zhou, and S. Wang, “Induction of necrotic cell death by oxidative stress in retinal pigment epithelial cells,” Cell Death & Disease, vol. 4, 2013. View at Publisher · View at Google Scholar
  • B. Marengo, C. Domenicotti, C.G. De Ciucis, R. Ricciarelli, A.L. Furfaro, R. Colla, E. Canepa, N. Traverso, U.M. Marinari, and M.A. Pronzato, “P38MAPK inhibition: A new combined approach to reduce neuroblastoma resistance under etoposide treatment,” Cell Death and Disease, vol. 4, no. 4, 2013. View at Publisher · View at Google Scholar
  • S Valdeolivas, M R Pazos, T Bisogno, F Piscitelli, F A Iannotti, M Allarà, O Sagredo, V Di Marzo, and J Fernández-Ruiz, “The inhibition of 2-arachidonoyl-glycerol (2-AG) biosynthesis, rather than enhancing striatal damage, protects striatal neurons from malonate-induced death: a potential role of cyclooxygenase-2-dependent metabolism of 2-AG,” Cell Death and Disease, vol. 4, no. 10, pp. e862, 2013. View at Publisher · View at Google Scholar
  • Y Zhang, J Xu, Y Xiao, S Ma, Q Liu, S Dang, M Jin, Y Shi, B Wan, and Y Zhang, “Inhibition of 12/15-lipoxygenase by baicalein induces microglia PPARβ/δ: a potential therapeutic role for CNS autoimmune disease,” Cell Death and Disease, vol. 4, no. 4, pp. e569, 2013. View at Publisher · View at Google Scholar
  • R. Martin Roop, and Clayton C. Caswell, “Bacterial Persistence: Finding the “Sweet Spot”,” Cell Host & Microbe, vol. 14, no. 2, pp. 119–120, 2013. View at Publisher · View at Google Scholar
  • Paula Martínez, Gonzalo Gómez-López, Fernando García, Evi Mercken, Sarah Mitchell, Juana M. Flores, Rafael de Cabo, and Maria A. Blasco, “RAP1 Protects from Obesity through Its Extratelomeric Role Regulating Gene Expression,” Cell Reports, 2013. View at Publisher · View at Google Scholar
  • Dana Foudah, Juliana Redondo, Cristina Caldara, Fabrizio Carini, Giovanni Tredici, and Mariarosaria Miloso, “Human mesenchymal stem cells express neuronal markers after osteogenic and adipogenic differentiation,” Cellular & Molecular Biology Letters, vol. 18, no. 2, pp. 163–186, 2013. View at Publisher · View at Google Scholar
  • Junmin Pan, Tamina Seeger-Nukpezah, and Erica A. Golemis, “The role of the cilium in normal and abnormal cell cycles: emphasis on renal cystic pathologies,” Cellular And Molecular Life Sciences, vol. 70, no. 11, pp. 1849–1874, 2013. View at Publisher · View at Google Scholar
  • Xie He, Jian-Lin Hu, Li Zhao, Yan Zhang, Yi-Jun Zeng, Shuang-Shuang Dai, and Feng-Tian He, “A feedback loop in PPARγ–adenosine A2A receptor signaling inhibits inflammation and attenuates lung damages in a mouse model of LPS-induced acute lung injury,” Cellular Signalling, 2013. View at Publisher · View at Google Scholar
  • Norman J. Karin, Richard A. Corley, Diana J. Bigelow, Joel G. Pounds, Susan C. Tilton, Katrina M. Waters, Vladimir Mikheev, K. Monica Lee, and Bobbie-Jo M. Webb-Robertson, “Impaired Transcriptional Response of the Murine Heart to Cigarette Smoke in the Setting of High Fat Diet and Obesity,” Chemical Research In Toxicology, vol. 26, no. 7, pp. 1034–1042, 2013. View at Publisher · View at Google Scholar
  • Yen Low, Alexander Y. Sedykh, Denis Fourches, Alexander Golbraikh, Maurice Whelan, Ivan Rusyn, and Alexander Tropsha, “Integrative Chemical-Biological Read-Across Approach for Chemical Hazard Classification,” Chemical Research in Toxicology, pp. 130712190613009, 2013. View at Publisher · View at Google Scholar
  • Vincenzo Carbone, and Tony Velkov, “Interaction of Phthalates and Phenoxy Acid Herbicide Environmental Pollutants with Intestinal Intracellular Lipid Binding Proteins,” Chemical Research in Toxicology, vol. 26, no. 8, pp. 1240–1250, 2013. View at Publisher · View at Google Scholar
  • Pengxiang Huang, Vikas Chandra, and Fraydoon Rastinejad, “Retinoic Acid Actions through Mammalian Nuclear Receptors,” Chemical Reviews, pp. 131205160911009, 2013. View at Publisher · View at Google Scholar
  • S. Jayanarayanan, S. Smijin, K.T. Peeyush, T.R. Anju, and C.S. Paulose, “NMDA and AMPA receptor mediated excitotoxicity in cerebral cortex of streptozotocin induced diabetic rat: Ameliorating effects of curcumin,” Chemico-Biological Interactions, vol. 201, no. 1-3, pp. 39–48, 2013. View at Publisher · View at Google Scholar
  • Yu-Chun Huang, Kao-Chih Liu, Yi-Ling Chiou, Chao-Hsun Yang, Tien-Hui Chen, Ting-Ting Li, and Li-Ling Liu, “Fenofibrate suppresses melanogenesis in B16-F10 melanoma cells via activation of the p38 mitogen-activated protein kinase pathway,” Chemico-Biological Interactions, 2013. View at Publisher · View at Google Scholar
  • Patrick D. McMullen, Sudin Bhattacharya, Courtney G. Woods, Bin Sun, Kathy Yarborough, Susan M. Ross, Manda E. Miller, Mary McBride, Edward L. LeCluyse, Rebecca A. Clewell, and Melvin E. Andersen, “A map of the PPARα transcription regulatory network for primary human hepatocytes,” Chemico-Biological Interactions, 2013. View at Publisher · View at Google Scholar
  • Beata Kolesinska, Dominika J. Podwysocka, Magnus A. Rueping, Dieter Seebach, Faustin Kamena, Peter Walde, Markus Sauer, Barbara Windschiegl, Mira Meyer-Acs, Marc Vor Der Brueggen, and Sebastian Giehring, “Permeation through Phospholipid Bilayers, Skin-Cell Penetration, Plasma Stability, and CD Spectra of a- and ss-Oligoproline Derivatives,” Chemistry & Biodiversity, vol. 10, no. 1, pp. 1–38, 2013. View at Publisher · View at Google Scholar
  • Alessandra Ammazzalorso, Barbara De Filippis, and Letizia Giampietro, “Blocking the Peroxisome Proliferator-Activated Receptor (PPAR): An Overview,” Chemmedchem, vol. 8, no. 10, pp. 1609–1616, 2013. View at Publisher · View at Google Scholar
  • Elena Grasselli, Katia Cortese, Adriana Voci, Laura Vergani, Rita Fabbri, Cristina Barmo, Gabriella Gallo, and Laura Canesi, “Direct effects of Bisphenol A on lipid homeostasis in rat hepatoma cells,” Chemosphere, vol. 91, no. 8, pp. 1123–1129, 2013. View at Publisher · View at Google Scholar
  • Eva Szabo, Jenny T. Mao, Stephen Lam, Mary E. Reid, and Robert L. Keith, “Chemoprevention of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines,” Chest, vol. 143, no. 5, pp. e40–e60, 2013. View at Publisher · View at Google Scholar
  • Qinqin Gong, Changjun Zhang, Yifei Dong, Ying Zhang, Xue Ru, and Xiaoning Wang, “The effects of curcumin on mouse testis oxidative damage induced by cyclophosphamide,” Chinese Journal of Andrology, vol. 27, no. 3, pp. 10–13, 2013. View at Publisher · View at Google Scholar
  • Bu-Chun Zhang, Xian-Kai Li, Wen-Liang Che, Wei-Ming Li, Lei Hou, Yi-Dong Wei, and Ya-Wei Xu, “Peroxisome proliferator-activated receptor α/γ agonist tesaglitazar stabilizes atherosclerotic plaque in diabetic low density lipoprotein receptor knockout mice,” Chinese Journal of Cardiology, vol. 41, no. 2, pp. 143–149, 2013. View at Publisher · View at Google Scholar
  • Gui-Zuo Wang, Jia-Mei Lu, Xin-Ming Xie, Dong Han, and Man-Xiang Li, “The role of PPARs in pulmonary diseases,” Chinese Pharmacological Bulletin, vol. 29, no. 1, pp. 18–22, 2013. View at Publisher · View at Google Scholar
  • Jonathan Q. Purnell, John E. Hokanson John E. Hokanson, Patricia A. Cleary, David M. Nathan, John M. Lachin, Bernard Zinman, and John D. Brunzell, “The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: Results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) study,” Circulation, vol. 127, no. 2, pp. 180–187, 2013. View at Publisher · View at Google Scholar
  • Bo Zhang, Emi Kawachi, Shin-ichiro Miura, Yoshinari Uehara, Akira Matsunaga, Masahide Kuroki, and Keijiro Saku, “Therapeutic Approaches to the Regulation of Metabolism of High-Density Lipoprotein - Novel HDL-Directed Pharmacological Intervention and Exercise -,” Circulation Journal, vol. 77, no. 11, pp. 2651–2663, 2013. View at Publisher · View at Google Scholar
  • Jiazhang Wei, Kazuhiko Takeuchi, and Hiroshi Watanabe, “Linoleic Acid Attenuates Endothelium-Derived Relaxing Factor Production by Suppressing cAMP-Hydrolyzing Phosphodiesterase Activity,” Circulation Journal, vol. 77, no. 11, pp. 2823–2830, 2013. View at Publisher · View at Google Scholar
  • Wai San Cheang, Xi Fang, and Xiao Yu Tian, “Pleiotropic Effects of Peroxisome Proliferator-Activated Receptor ^|^gamma; and ^|^delta; in Vascular Diseases,” Circulation Journal, vol. 77, no. 11, pp. 2664–2671, 2013. View at Publisher · View at Google Scholar
  • Kimio Satoh, “Linoleic Acid - A Novel Mechanism of Endothelial Cell Dysfunction -,” Circulation Journal, vol. 77, no. 11, pp. 2702–2703, 2013. View at Publisher · View at Google Scholar
  • Xavier Palomer, “Cambios en el proteoma del miocardio en un modelo experimental de diabetes crónica e hipertensión: papel de receptor activado por proliferadores peroxisómicos de tipo alfa en la hipertrofia asociada,” Clínica e Investigación en Arteriosclerosis, vol. 25, no. 1, pp. 48–50, 2013. View at Publisher · View at Google Scholar
  • B. M. Brooks-Worrell, and J. P. Palmer, “Attenuation of islet-specific T cell responses is associated with C-peptide improvement in autoimmune type 2 diabetes patients,” Clinical & Experimental Immunology, vol. 171, no. 2, pp. 164–170, 2013. View at Publisher · View at Google Scholar
  • Osvaldo Fridman, Rafael Porcile, Analía V. Morales, Luis O. Gariglio, Miguel A. Potenzoni, and Paula C. Turk Noceto, “Association of Methylenetetrahydrofolate Reductase Gene 677C>T Polymorphism with Hypertension in Older Women in a Population of Buenos Aires City,” Clinical and Experimental Hypertension, vol. 35, no. 3, pp. 159–166, 2013. View at Publisher · View at Google Scholar
  • Mitchell Lock, Erin V McGillick, Sandra Orgeig, I Caroline McMillen, and Janna L Morrison, “Regulation of fetal lung development in response to maternal overnutrition,” Clinical and Experimental Pharmacology and Physiology, vol. 40, no. 11, pp. 803–816, 2013. View at Publisher · View at Google Scholar
  • Dana Greene-Schloesser, Elizabeth Moore, and Mike E. Robbins, “Molecular Pathways: Radiation-Induced Cognitive Impairment,” Clinical Cancer Research, vol. 19, no. 9, pp. 2294–2300, 2013. View at Publisher · View at Google Scholar
  • Yan Xu, Qingchun Cai, and Libo Yan, “The Ubiquitin-CXCR4 Axis Plays an Important Role in Acute Lung Infection-Enhanced Lung Tumor Metastasis,” Clinical Cancer Research, vol. 19, no. 17, pp. 4706–4716, 2013. View at Publisher · View at Google Scholar
  • Eun-Jung Bak, Jinmoon Kim, Yun Hui Choi, Ji-Hye Kim, Dong-Eun Lee, Gye-Hyeong Woo, Jeong-Heon Cha, and Yun-Jung Yoo, “Wogonin ameliorates hyperglycemia and dyslipidemia via PPARα activation in db/db mice,” Clinical Nutrition, 2013. View at Publisher · View at Google Scholar
  • Fabio Mazzolani, and Stefano Togni, “Oral administration of a curcumin-phospholipid delivery system for the treatment of central serous chorioretinopathy: A 12-month follow-up study,” Clinical Ophthalmology, vol. 7, pp. 939–945, 2013. View at Publisher · View at Google Scholar
  • Luca Steardo, and Caterina Scuderi, “Neuroglial Roots of Neurodegenerative Diseases: Therapeutic Potential of Palmitoylethanolamide in Models of Alzheimer's Disease,” Cns & Neurological Disorders-Drug Targets, vol. 12, no. 1, pp. 62–69, 2013. View at Publisher · View at Google Scholar
  • Fredrik F. Venold, Michael H. Penn, Jim Thorsen, Jinni Gu, Trond M. Kortner, Ashild Krogdahl, and Anne Marie Bakke, “Intestinal fatty acid binding protein (fabp2) in Atlantic salmon (Salmo salar): Localization and alteration of expression during development of diet induced enteritis,” Comparative Biochemistry And Physiology A-Molecular & Integrative Physiolog, vol. 164, no. 1, pp. 229–240, 2013. View at Publisher · View at Google Scholar
  • L. Filipe C. Castro, Alexandre Lobo-da-Cunha, Maria J. Rocha, Ralph Urbatzka, and Eduardo Rocha, “Pex11α in brown trout (Salmo trutta f. fario): Expression dynamics during the reproductive cycle reveals sex-specific seasonal patterns,” Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology, vol. 164, no. 1, pp. 207–214, 2013. View at Publisher · View at Google Scholar
  • Swati Singh, Veda P Pandey, Huma Naaz, Priyanka Singh, and Upendra N. Dwivedi, “Structural modeling and simulation studies of human cyclooxygenase (COX) isozymes with selected terpenes: Implications in drug designing and development,” Computers in Biology and Medicine, vol. 43, no. 6, pp. 744–750, 2013. View at Publisher · View at Google Scholar
  • Ozgur Omur, and Yusuf Baran, “An Update On Molecular Biology Of Thyroid Cancers,” Critical Reviews in Oncology/Hematology, 2013. View at Publisher · View at Google Scholar
  • Vanessa R. Kay, Christina Chambers, and Warren G. Foster, “Reproductive and developmental effects of phthalate diesters in females,” Critical Reviews In Toxicology, vol. 43, no. 3, pp. 200–219, 2013. View at Publisher · View at Google Scholar
  • J. Christopher Corton, Michael L. Cunningham, B. Timothy Hummer, Christopher Lau, Bette Meek, Jeffrey M. Peters, James A. Popp, Lorenz Rhomberg, Jennifer Seed, and James E. Klaunig, “ Mode of action framework analysis for receptor-mediated toxicity: The peroxisome proliferator-activated receptor alpha (PPAR α ) as a case study ,” Critical Reviews in Toxicology, pp. 1–49, 2013. View at Publisher · View at Google Scholar
  • Silvia Zappavigna, Michele Caraglia, Annamaria Colao, Alessandra Dicitore, Daniela Mari, Giovanni Vitale, Luca Persani, and Leo J. Hofland, “Combined Treatment with PPAR-gamma Agonists in Pancreatic Cancer: A Glimmer of Hope for Cancer Therapy?,” Current Cancer Drug Targets, vol. 13, no. 4, pp. 460–471, 2013. View at Publisher · View at Google Scholar
  • Chin-Chi Kuo, Katherine Moon, Kristina A. Thayer, and Ana Navas-Acien, “Environmental Chemicals and Type 2 Diabetes: An Updated Systematic Review of the Epidemiologic Evidence,” Current Diabetes Reports, vol. 13, no. 6, pp. 831–849, 2013. View at Publisher · View at Google Scholar
  • K. Sandy Pang, and Edwin C. Y. Chow, “Why We Need Proper PBPK Models to Examine Intestine and Liver Oral Drug Absorption,” Current Drug Metabolism, vol. 14, no. 1, pp. 57–79, 2013. View at Publisher · View at Google Scholar
  • Osama H. Elshenawy, Ayman O. S. El-Kadi, and Anwar Anwar-Mohamed, “20-Hydroxyeicosatetraenoic Acid is a Potential Therapeutic Target in Cardiovascular Diseases,” Current Drug Metabolism, vol. 14, no. 6, pp. 706–719, 2013. View at Publisher · View at Google Scholar
  • Patrick G. Sullivan, and Heather M. Yonutas, “Targeting PPAR Isoforms Following CNS Injury,” Current Drug Targets, vol. 14, no. 7, pp. 733–742, 2013. View at Publisher · View at Google Scholar
  • Anna R. Carta, “PPAR-gamma: Therapeutic Prospects in Parkinson's Disease,” Current Drug Targets, vol. 14, no. 7, pp. 743–751, 2013. View at Publisher · View at Google Scholar
  • Sophie Gautier, Bart Staels, Dominique Deplanque, Patrick Duriez, Michele Bastide, Regis Bordet, Thavarak Ouk, Didier Leys, and Camille Potey, “PPARs: A Potential Target for a Disease-Modifying Strategy in Stroke,” Current Drug Targets, vol. 14, no. 7, pp. 752–767, 2013. View at Publisher · View at Google Scholar
  • M. Scotece, J. J. Gomez-Reino, V. Lopez, F. Lago, J. Pino, and J. Conde, “Leptin in Joint and Bone Diseases: New Insights,” Current Medicinal Chemistry, vol. 20, no. 27, pp. 3416–3425, 2013. View at Publisher · View at Google Scholar
  • G. Sambataro, P. Piccinni, C. Spina, F. M. Sambataro, L. Navarini, and A. Dobrina, “Hepatic PPARs: Their Role in Liver Physiology, Fibrosis and Treatment,” Current Medicinal Chemistry, vol. 20, no. 27, pp. 3370–3396, 2013. View at Publisher · View at Google Scholar
  • V. Gasperi, E. Dainese, S. Oddi, A. Sabatucci, and M. Maccarrone, “GPR55 and its interaction with membrane lipids: Comparison with other endocannabinoid-binding receptors,” Current Medicinal Chemistry, vol. 20, no. 1, pp. 64–78, 2013. View at Publisher · View at Google Scholar
  • U. R. Markert, A. Pestka, J. S. Fitzgerald, and B. Toth, “Nuclear Hormone Receptors and Female Reproduction,” Current Molecular Medicine, vol. 13, no. 7, pp. 1066–1078, 2013. View at Publisher · View at Google Scholar
  • S. Baldelli, M. R. Ciriolo, B. Pagliei, and K. Aquilano, “Extranuclear Localization of SIRT1 and PGC-1 alpha: An Insight into Possible Roles in Diseases Associated with Mitochondrial Dysfunction,” Current Molecular Medicine, vol. 13, no. 1, pp. 140–154, 2013. View at Publisher · View at Google Scholar
  • Carole A. Conn, Roger A. Vaughan, and William S. Garver, “Nutritional Genetics and Energy Metabolism in Human Obesity,” Current Nutrition Reports, 2013. View at Publisher · View at Google Scholar
  • Laureane N. Masi, Alice C. Rodrigues, and Rui Curi, “Fatty acids regulation of inflammatory and metabolic genes,” Current Opinion in Clinical Nutrition and Metabolic Care, pp. 1, 2013. View at Publisher · View at Google Scholar
  • Emily J. Gallagher, and Derek LeRoith, “Diabetes, antihyperglycemic medications and cancer risk,” Current Opinion in Endocrinology & Diabetes and Obesity, vol. 20, no. 5, pp. 485–494, 2013. View at Publisher · View at Google Scholar
  • William T Gerthoffer, Julian Solway, and Blanca Camoretti-Mercado, “Emerging targets for novel therapy of asthma,” Current Opinion in Pharmacology, 2013. View at Publisher · View at Google Scholar
  • Jenny Cook, and Thorsten Hagemann, “Tumour-associated macrophages and cancer,” Current Opinion in Pharmacology, 2013. View at Publisher · View at Google Scholar
  • Malgorzata Pierzchalska, Krzysztof Reiss, and Maja Grabacka, “Peroxisome Proliferator Activated Receptor alpha Ligands as Anticancer Drugs Targeting Mitochondrial Metabolism,” Current Pharmaceutical Biotechnology, vol. 14, no. 3, pp. 342–356, 2013. View at Publisher · View at Google Scholar
  • Leandro Martin Velez, Alicia Beatriz Motta, and Giselle Adriana Abruzzese, “The Biology of the Peroxisome Proliferator-activated Receptor System in the Female Reproductive Tract,” Current Pharmaceutical Design, vol. 19, no. 25, pp. 4641–4646, 2013. View at Publisher · View at Google Scholar
  • Maria Cristina Manara, Antonino Belfiore, Stefano Ferrari, Cecilia Garofalo, and Katia Scotlandi, “Designing Novel Therapies Against Sarcomas in the Era of Personalized Medicine and Economic Crisis,” Current Pharmaceutical Design, vol. 19, no. 30, pp. 5344–5361, 2013. View at Publisher · View at Google Scholar
  • Michael S. Kostapanos, and Moses S. Elisaf, “Pioglitazone and Cancer: Angel or Demon?,” Current Pharmaceutical Design, vol. 19, no. 27, pp. 4913–4929, 2013. View at Publisher · View at Google Scholar
  • Milagros Rocha, Rosa Falcon, Jose R. Herance, Antonio Hernandez-Mijares, Carlos Morillas, Celia Banuls, Susana Rovira-Llopis, Lorena Bellod, and Raquel Castello, “Mitochondrial Dysfunction and Oxidative Stress in Insulin Resistance,” Current Pharmaceutical Design, vol. 19, no. 32, pp. 5730–5741, 2013. View at Publisher · View at Google Scholar
  • Wyi Sian Lim, Di Lin Ng, Sue Bee Kor, Hong Kin Wong, Tengku Sifzizul Tengku-Muhammad, Quok Cheong Choo, and Choy Hoong Chew, “Tumour necrosis factor alpha down-regulates the expression of peroxisome proliferator activated receptor alpha (PPARα) in human hepatocarcinoma HepG2 cells by activation of NF-κB pathway,” Cytokine, vol. 61, no. 1, pp. 266–274, 2013. View at Publisher · View at Google Scholar
  • U. Jeschke, “Plazentaforschung,” Der Gynäkologe, vol. 46, no. 11, pp. 798–802, 2013. View at Publisher · View at Google Scholar
  • Wen-Yan Li, Yang-Liu Song, Cheng-Juan Xiong, Pei-Qi Lu, Li-Xiang Xue, Chun-Xia Yao, Wei-Ping Wang, Shu-Feng Zhang, Shan-Feng Zhang, Qing-Xia Wei, Yan-Yan Zhang, Ji-Min Zhao, and Ming-Xi Zang, “Insulin induces proliferation and cardiac differentiation of P19CL6 cells in a dose-dependent manner,” Development, Growth & Differentiation, vol. 55, no. 7, pp. 676–686, 2013. View at Publisher · View at Google Scholar
  • Sanshiro Tateya, Alexander W. Clowes, Alan Chait, Francis Kim, Norma Rizzo-De Leon, Priya Handa, Andrew M. Cheng, Vicki Morgan-Stevenson, Kayoko Ogimoto, Jenny E. Kanter, Karin E. Bornfeldt, and Guenter Daum, “VASP increases hepatic fatty acid oxidation by activating AMPK in mice,” Diabetes, vol. 62, no. 6, pp. 1913–1922, 2013. View at Publisher · View at Google Scholar
  • Li Wang, Ruifeng Teng, Lijun Di, Heather Rogers, Hong Wu, Jeffrey B. Kopp, and Constance Tom Noguchi, “PPAR alpha and Sirt1 Mediate Erythropoietin Action in Increasing Metabolic Activity and Browning of White Adipocytes to Protect Against Obesity and Metabolic Disorders,” Diabetes, vol. 62, no. 12, pp. 4122–4131, 2013. View at Publisher · View at Google Scholar
  • Hannah Seok, and Bong Soo Cha, “Refocusing Peroxisome Proliferator Activated Receptor-α: A New Insight for Therapeutic Roles in Diabetes,” Diabetes & Metabolism Journal, vol. 37, no. 5, pp. 326, 2013. View at Publisher · View at Google Scholar
  • Cesar Corzo, and Patrick R. Griffin, “Targeting the Peroxisome Proliferator-Activated Receptor-γ to Counter the Inflammatory Milieu in Obesity,” Diabetes & Metabolism Journal, vol. 37, no. 6, pp. 395, 2013. View at Publisher · View at Google Scholar
  • Qibin Qi, James B. Meigs, Kathryn M. Rexrode, Frank B. Hu, and Lu Qi, “Diabetes Genetic Predisposition Score and Cardiovascular Complications Among Patients With Type 2 Diabetes,” Diabetes Care, vol. 36, no. 3, pp. 737–739, 2013. View at Publisher · View at Google Scholar
  • Philip Home, “Insulin Therapy and Cancer,” Diabetes Care, vol. 36, pp. S240–S244, 2013. View at Publisher · View at Google Scholar
  • George Grunberger, “Will PPAR-γ agonist therapy still have a role in diabetes management in 2013?,” Diabetes Management, vol. 3, no. 1, pp. 41–51, 2013. View at Publisher · View at Google Scholar
  • A. Consoli, and G. Formoso, “Do thiazolidinediones still have a role in treatment of type 2 diabetes mellitus?,” Diabetes, Obesity and Metabolism, 2013. View at Publisher · View at Google Scholar
  • S. K. Garg, H. Maurer, K. Reed, and R. Selagamsetty, “Diabetes and cancer: two diseases with obesity as a common risk factor,” Diabetes, Obesity and Metabolism, 2013. View at Publisher · View at Google Scholar